Press Release: Mergers: Commission approves acquisition of Swedish medical technology company Gambro by US rival Baxter, subject to conditions

The European Commission has authorised under the EU Merger Regulation the proposed acquisition of the Swedish dialysis equipment manufacturer Gambro by US rival healthcare company Baxter.

The clearance is conditional upon the divestment of Baxter's continuous renal replacement therapy (CRRT) business which serves patients suffering from acute kidney failure. The Commission had concerns that the transaction as originally notified would have reduced effective competition on this market. The commitments submitted by Baxter adequately address these concerns.